Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
8
Bearish filings
21
Named actors
10
Disclosed $ (bull / bear)
$264K + 2 of unknown size / $1.9M + 2 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-29 | 5%+ holder (13G) — reduced stake Aberdeen Group plc | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-10-26 | Chief Executive Officer REICIN ALISE | exercised options & held the shares | $24K | SEC ↗ |
| 2026-09-30 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PETER MCNAMARA | filed notice to sell | $12K | SEC ↗ |
| 2026-09-30 | Chief Scientific Officer McNamara Peter | sold | $12K | SEC ↗ |
| 2026-08-27 | Former Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) TERRANCE MCGUIRE | filed notice to sell | $277K |
4 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-25 | Chief Scientific Officer McNamara Peter | sold | $2K | SEC ↗ |
| 2026-08-21 | Former Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) TERRANCE MCGUIRE | filed notice to sell | $384K | SEC ↗ |
| 2026-08-12 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PETER MCNAMARA | filed notice to sell | $4K | SEC ↗ |
| 2026-06-30 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PETER MCNAMARA | filed notice to sell | $6K | SEC ↗ |
| 2026-06-30 | Chief Scientific Officer McNamara Peter | sold | $6K | SEC ↗ |
| 2026-05-04 | Chief Medical Officer Ruddy Marcella K. | sold | $32K | SEC ↗ |
| 2026-04-01 | Chief Medical Officer Ruddy Marcella K. | sold | $31K | SEC ↗ |
| 2026-03-06 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MARCELLA RUDDY | filed notice to sell | $336K | SEC ↗ |
| 2026-03-06 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PETER MCNAMARA | filed notice to sell | $174K | SEC ↗ |
| 2026-03-06 | Chief Scientific Officer McNamara Peter | sold | $181K | SEC ↗ |
| 2026-03-06 | Chief Scientific Officer McNamara Peter | sold | $8K | SEC ↗ |
| 2026-03-06 | Chief Medical Officer Ruddy Marcella K. | sold | $300K | SEC ↗ |
| 2026-03-04 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PETER MCNAMARA | filed notice to sell | $40K | SEC ↗ |
| 2026-03-04 | Chief Scientific Officer McNamara Peter | sold | $41K | SEC ↗ |
| 2026-03-03 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PETER MCNAMARA | filed notice to sell | $38K | SEC ↗ |
| 2026-03-03 | Chief Scientific Officer McNamara Peter | sold | $36K | SEC ↗ |
| 2026-02-27 | 5%+ holder (13G) TCG Crossover GP II, LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-11 | Chief Executive Officer REICIN ALISE | bought | $53K | SEC ↗ |
| 2026-02-10 | Chief Financial Officer Lochner Daniel | bought | $130K | SEC ↗ |
| 2026-02-10 | Chief Business Officer Schwabish Marc | exercised options & held the shares | $11K | — |